Steven Valiquette
Stock Analyst at Mizuho
(3.80)
# 654
Out of 4,896 analysts
110
Total ratings
63.64%
Success rate
5.42%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Outperform | $48 | $37.36 | +28.48% | 1 | Jun 30, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $280 → $295 | $275.89 | +6.93% | 3 | Jun 2, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $60.20 | -0.33% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $202.28 | +21.12% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $709.59 | -2.76% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $160.97 | -6.81% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $16.21 | +11.04% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $73.80 | +11.11% | 2 | Mar 3, 2025 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $11.26 | -37.83% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $94.48 | +33.36% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $73.44 | +2.13% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.64 | +89.39% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $20 | $20.20 | -0.99% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $8.12 | +72.41% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $182.52 | -22.20% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $64.77 | -15.08% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $155.16 | -40.71% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $304.10 | +85.79% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $64.78 | +54.37% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.13 | +238.98% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $221.55 | +80.55% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $31.44 | +240.33% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $30.73 | -44.68% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $7.93 | +51.32% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $118.43 | -18.94% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $168.09 | -28.61% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $376.07 | -66.23% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $230.67 | +55.20% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.52 | +420.83% | 3 | Apr 3, 2019 |
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $37.36
Upside: +28.48%
Veeva Systems
Jun 2, 2025
Maintains: Outperform
Price Target: $280 → $295
Current: $275.89
Upside: +6.93%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $60.20
Upside: -0.33%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $202.28
Upside: +21.12%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $709.59
Upside: -2.76%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $160.97
Upside: -6.81%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $16.21
Upside: +11.04%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $73.80
Upside: +11.11%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $11.26
Upside: -37.83%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $94.48
Upside: +33.36%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $73.44
Upside: +2.13%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.64
Upside: +89.39%
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $20.20
Upside: -0.99%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $8.12
Upside: +72.41%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $182.52
Upside: -22.20%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $64.77
Upside: -15.08%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $155.16
Upside: -40.71%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $304.10
Upside: +85.79%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $64.78
Upside: +54.37%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.13
Upside: +238.98%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $221.55
Upside: +80.55%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $31.44
Upside: +240.33%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $30.73
Upside: -44.68%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $7.93
Upside: +51.32%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $118.43
Upside: -18.94%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $168.09
Upside: -28.61%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $376.07
Upside: -66.23%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $230.67
Upside: +55.20%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.52
Upside: +420.83%